Trial Profile
Effect of Standardized Perioperative Dabigatran Interruption on Residual Anticoagulation Effect at the Time of Surgery or Procedure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- 05 Nov 2015 New trial record
- 29 Oct 2015 Results published in the Journal of Thrombosis and Haemostasis